Find policies, billing codes, payers, states, and providers
Loading...
Find policies, billing codes, payers, states, and providers
CPT 64600: Trigeminal Nerve Neurodestruction by Injection
CPT-64605-TRIGEMINAL-NERVE-NEURODESTRUCTIVE-INJECTIONCPT 64605: Trigeminal Nerve Neurodestructive Injection
CPT-64610-TRIGEMINAL-NERVE-NEURODESTRUCTIVE-INJECTIONCPT 64610: Trigeminal Nerve Neurodestructive Injection
CPT-64611-SALIVARY-GLAND-CHEMICAL-DENERVATION-BILATERALCPT 64611: Bilateral Salivary Gland Chemical Injection for Sialorrhea
CPT-64612-FACIAL-NERVE-CHEMICAL-NEUROLYSIS-UNILATERALCPT 64612: Facial Nerve Chemical Neurolysis, Unilateral
CPT-64615-BILATERAL-CHEMICAL-DENERVATION-FACIAL-CERVICAL-MUSCLESCPT 64615: Bilateral Chemical Denervation of Head and Neck Muscles
CPT-64616-UNILATERAL-CERVICAL-MUSCLE-CHEMICAL-DENERVATIONCPT 64616: Unilateral Neck Muscle Chemodenervation
CPT-64617-PERCUTANEOUS-LARYNGEAL-CHEMODENERVATION-UNILATERALCPT 64617: Percutaneous Chemodenervation of Larynx, Unilateral
CPT-64620-INTERCOSTAL-NERVE-ABLATIONCPT 64620: Intercostal Nerve Destruction (Chemical/Heat/Radiofrequency)
CPT-64624-GENICULAR-NERVE-NEUROLYSIS-KNEECPT 64624: Genicular Nerve Neurolysis for Knee Pain
Showing 1–10 of 27
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.